SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-20-032787
Filing Date
2020-03-13
Accepted
2020-03-13 08:57:43
Documents
7
Period of Report
2020-03-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2012665-2_6k.htm 6-K 17007
2 EXHIBIT 99.1 tm2012665d2_ex99-1.htm EX-99.1 73250
3 EXHIBIT 99.2 tm2012665d2_ex99-2.htm EX-99.2 17332
4 EXHIBIT 99.3 tm2012665d2_ex99-3.htm EX-99.3 72231
5 EXHIBIT 99.4 tm2012665d2_ex99-4.htm EX-99.4 339991
6 GRAPHIC tm2012665d2_ex99-1img001.jpg GRAPHIC 16170
7 GRAPHIC tm201665d2_ex99-4img01.jpg GRAPHIC 15104
  Complete submission text file 0001104659-20-032787.txt   564231
Mailing Address SMEDELAND 36 2600 GLOSTRUP COPENHAGEN G7 00000
Business Address SMEDELAND 36 2600 GLOSTRUP COPENHAGEN G7 00000 4588773600
Zealand Pharma A/S (Filer) CIK: 0001674988 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38178 | Film No.: 20710841
SIC: 2834 Pharmaceutical Preparations